仁東控股(002647.SZ):景華及潤澤2號基金合計持股比例降至5%以下
格隆匯 8 月 29日丨仁東控股(002647.SZ)公佈,截至2020年8月28日,信息披露義務人景華主動減持仁東控股1887.19萬股的目的為降低股票質押比例;信息披露義務人潤澤2號基金的所持股份因被重慶國際信託股份有限公司採取平倉措施,被動減持52.25萬股。
信息披露義務人景華及潤澤2號基金在2020年5月21日至2020年8月28日期間,通過集中競價方式累計減持公司股份1939.44萬股,佔仁東控股總股本的3.46%。
此次權益變動後,景華及潤澤2號基金合計持有股份2799.68萬股,持股比例4.99999%。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.